News

2016 Apr 18

First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer

Scott Tagawa, M.D., M.S., discusses the results of a phase I/II trial into a promising new immunotherapy drug for bladder cancer. Read more

Photo of Drs. Rubin, Sboner, Beltran and Elemento

2016 Apr 17

Englander Institute joins international genomic medicine effort

Tumors sequenced at Weill Cornell Medicine/NewYork-Presbyterian could help further cancer research across the globe, as part of the International Cancer Genome Consortium Read more

2016 Apr 15

Panoply of new agents, complete remission rates mark ‘special day’ in myeloma

Ruben Niesvizky, M.D., discusses the “privilege” of caring for patients with myeloma in an era of therapeutic milestones. Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2016 Apr 15

The promise of combining radiotherapy and immunotherapy to treat cancer

Silvia Formenti, M.D., discusses her novel approach to immunotherapy using radiation treatment. Read more

Ekta Khurana, Ph.D., assistant professor of computational biology at the Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 14

Cancer genomics: Hard-to-reach repairs

Ekta Khurana, Ph.D., comments on two studies about DNA repair mechanisms. Read more

Doctors at Meyer Cancer Center are enrolling cancer patients in immunotherapy trials

2016 Apr 13

Lymphoma researchers earn Top 10 Clinical Research Award

The lymphoma clinical research group has received a Clinical Research Forum award for its study demonstrating the efficacy of an innovative combination therapy for treating mantle cell lymphoma. Read more

2016 Apr 13

Unraveling how obesity fuels cancer

Andrew Dannenberg, M.D., discusses the effect of inflammation and aromatase expression on breast cancer risk. Read more

2016 Apr 11

A Pathway to Success: Studying signal transduction in cancer and other diseases

Lewis Cantley, Ph.D., discusses his career in science Read more

2016 Apr 08

Scientists push to expand survival rates for brain cancer patients

One size does not fit all for brain cancer treatment, says Howard Fine, M.D. Read more

2016 Apr 08

The transformation of oncology

We are living in a remarkable time for cancer research - let's take advantage of it, says Harold Varmus, M.D., Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 08

A career in cancer research? Computational skills wanted

Marcin Imielinski, M.D., Ph.D., and Mark Rubin, M.D., discuss burgeoning career options in cancer research. Read more

2016 Apr 06

Cancer metastases: Are one and all the same?

Himisha Beltran, M.D., comments on a study on prostate cancer pathogenesis and metastasis. Read more

2016 Apr 06

Most cancer patients have overly optimistic view of their life expectancy

Most patients have an overly optimistic view of their life expectancy and that few patients base their estimate on communications with their healthcare providers, said Holly Prigerson, Ph.D. Read more

2016 Apr 04

How not to end cancer in our lifetimes

Dean Laurie Glimcher, M.D., discusses proposed rules governing the usage of human tissue in research. Read more

2016 Apr 04

When to treat patients with follicular lymphoma

John Leonard, M.D., talks to Targeted Oncology about treatment options for patients with follicular lymphoma. Read more

2016 Apr 01

Broccoli sheds light on RNA-modifying enzymes

The lab of Samie Jaffrey, M.D., Ph.D., has created Broccoli, a derivative of the Spinach fluorescent aptamer for assaying RNA-modifying enzymes. Read more